Home Cart Sign in  
Chemical Structure| 2242952-69-6 Chemical Structure| 2242952-69-6

Structure of BMS-986299
CAS No.: 2242952-69-6

Chemical Structure| 2242952-69-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-986299 is an NLRP3 inflammasome activator with an EC50 of 1.28 μM. BMS-986299 activates the NLRP3 inflammasome and is used in research related to inflammatory diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-986299

CAS No. :2242952-69-6
Formula : C18H19N7O
M.W : 349.39
SMILES Code : CCN(C(C)=O)CC1=NC2=C(C(N)=NC3=C2C=CC(C4=CC=NN4)=C3)N1
MDL No. :MFCD34567729

Safety of BMS-986299

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BV2 cells 5 μM 24 h To evaluate the effect of CPCGI on LPS-induced inflammatory response in BV2 cells, results showed that CPCGI significantly reduced IL-6 levels. PMC11890976

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Traumatic brain injury (TBI) model Intraperitoneal injection 10 mg/kg/day Once daily until the end of the experiment To evaluate the effect of BMS-986299 on NLRP3 inflammasome activation in the TBI model, results showed that BMS-986299 reversed the neuroprotective effects of CPCGI. PMC11890976

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.86mL

0.57mL

0.29mL

14.31mL

2.86mL

1.43mL

28.62mL

5.72mL

2.86mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories